Reviewer #1 (Public Review): Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers
Year: 2024
Type: peer-review
Source: eLife
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,500
Funders: Broad Institute, Foghorn Therapeutics
OpenAlex ID: W4394808709
